Buket Yilmaz Bulbul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Buket Yilmaz Bulbul has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Mehmet Celik
Department of Internal Medicine, Division of Endocrinology and Metabolism, Faculty of Medicine, Trakya University, 22030 Edirne, Türkiye
3 shared publications - Burak Andaç
Department of Internal Medicine, Division of Endocrinology and Metabolism, Faculty of Medicine, Trakya University, 22030 Edirne, Türkiye
2 shared publications - Eray Özgün
Department of Medical Biochemistry , 37521 Trakya University School of Medicine , Edirne , Türkiye
2 shared publications - Mine Okur
Trakya Universitesi, Tip Fakultesi
2 shared publications - Serpil Yanık Çolak
Department of Endocrinology and Metabolism, Trakya University Medical Faculty, Edirne 22000, Turkey
2 shared publications - Ahmet Küçükarda
Department of Medical Oncology, Faculty of Medicine, Trakya University, 22030 Edirne, Türkiye
1 shared publication
Latest Publications
- Open Access
- 19 September 2024
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (5) , 691-697
Relationship of paraoxonase-1 and paraoxonase-3 with routine laboratory tests and oxidative stress in type 2 diabetes mellitus
Objectives: We aimed to investigate the relationship between serum paraoxonase-1 (PON1) and paraoxonase-3 (PON3) levels and activities with hemoglobin A1c (HbA 1c ), serum fasting blood glucose, lipid profile, and oxidative stress in patients with type 2 diabetes mellitus (T2DM). Also, we aimed to examine PON1 and PON3 levels and activities in these patients according to the HbA 1c goal in diabetes treatment and PON1 192 phenotypes. Methods: One hundred forty-one volunteers diagnosed with T2DM participated in this study. Serum PON1 and PON3 levels and activities, total oxidant status (TOS), and total antioxidant status (TAS) were measured. PON1 192 phenotypes were determined by using PON1 activities. Also, HbA 1c , serum fasting blood glucose, and lipid profile results, which were measured for routine examination on the same day as sample collection, were used for this study. Results: There was a positive relationship between arylesterase and lactonase activities and high-density lipoprotein cholesterol (HDL-C), between lactonase activity and TAS, and a negative relationship between PON1 level and TAS in patients with T2DM. Our study also showed that PON3/HDL-C was higher in patients with HbA 1c levels ≥7 %. Lactonase activities were higher in patients with PON1 Q192Q and PON1 Q192R phenotypes than in patients with PON1 R192R phenotypes. Conclusions: PON1 and PON3 levels and activities alone could not be associated with immediate or long-term blood glucose levels in patients with T2DM. Higher PON3/HDL-C in patients with HbA 1c levels ≥7 % may show a protective role of PON3 in defense against higher glucose levels. Also, we found that the PON1 192 phenotype can affect serum lactonase activity.
- 19 September 2024
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (5) , 691-697
Open AccessRelationship of paraoxonase-1 and paraoxonase-3 with routine laboratory tests and oxidative stress in type 2 diabetes mellitus
Objectives: We aimed to investigate the relationship between serum paraoxonase-1 (PON1) and paraoxonase-3 (PON3) levels and activities with hemoglobin A1c (HbA 1c ), serum fasting blood glucose, lipid profile, and oxidative stress in patients with type 2 diabetes mellitus (T2DM). Also, we aimed to examine PON1 and PON3 levels and activities in these patients according to the HbA 1c goal in diabetes treatment and PON1 192 phenotypes. Methods: One hundred forty-one volunteers diagnosed with T2DM participated in this study. Serum PON1 and PON3 levels and activities, total oxidant status (TOS), and total antioxidant status (TAS) were measured. PON1 192 phenotypes were determined by using PON1 activities. Also, HbA 1c , serum fasting blood glucose, and lipid profile results, which were measured for routine examination on the same day as sample collection, were used for this study. Results: There was a positive relationship between arylesterase and lactonase activities and high-density lipoprotein cholesterol (HDL-C), between lactonase activity and TAS, and a negative relationship between PON1 level and TAS in patients with T2DM. Our study also showed that PON3/HDL-C was higher in patients with HbA 1c levels ≥7 %. Lactonase activities were higher in patients with PON1 Q192Q and PON1 Q192R phenotypes than in patients with PON1 R192R phenotypes. Conclusions: PON1 and PON3 levels and activities alone could not be associated with immediate or long-term blood glucose levels in patients with T2DM. Higher PON3/HDL-C in patients with HbA 1c levels ≥7 % may show a protective role of PON3 in defense against higher glucose levels. Also, we found that the PON1 192 phenotype can affect serum lactonase activity.
- 8 December 2023
- Published by Galenos Yayinevi in Namık Kemal Tıp Dergisi
- Vol. 11 (4) , 395-399
Falsely Elevated Thyroid Stimulating Hormone in Two Cases Requiring Special Follow-up
- 8 December 2023
- Published by Galenos Yayinevi in Namık Kemal Tıp Dergisi
- Vol. 11 (4) , 395-399
Falsely Elevated Thyroid Stimulating Hormone in Two Cases Requiring Special Follow-up
- Open Access
- 31 October 2023
- Published by Akdeniz University in Akdeniz Medical Journal
- Vol. 10 (2) , 284-288
25-Hydroxyvitamin D Status In Type 1 Diabetic Adults And Its Relationship With Glycemic Control
Objective: To assess the vitamin D levels between adults with type 1 diabetes mellitus and the healthy control group and evaluate the relationship between HbA1c levels and vitamin D status in the diabetic group. Methods: Our cross-sectional, descriptive study included 98 type 1 diabetic patients over 18 years old who applied to the Endocrinology Outpatient Clinic and 95 age- and sex-matched individuals without chronic disease. Patients with advanced renal or liver disorders, primary hyperparathyroidism, metabolic bone disorders, or using medications that might change vitamin D concentrations were excluded from the study. HbA1c and 25(OH) Vitamin-D3 levels were measured three times in 9 months, and the average of the measurements was used. Diabetic patients and control individuals were separated into three groups according to their vitamin D levels as follows: deficiency ( 20 ng/ml). Results: Serum 25 (OH) vitamin D levels of diabetic patients were significantly lower than in healthy individuals (p=0.024). However, when diabetic adults were separated into three groups according to 25(OH) vitamin D levels, there was no significant difference regarding HbA1c levels (p=0.905). Conclusion: Although preclinical data support the role of low serum vitamin D levels in the etiopathogenesis of type 1 diabetes mellitus, studies examining the connection between low serum vitamin D levels and the prevalence of type 1 diabetes or glycemic control are not sufficient to reach a clear conclusion, including our study.
- 31 October 2023
- Published by Akdeniz University in Akdeniz Medical Journal
- Vol. 10 (2) , 284-288
Open Access25-Hydroxyvitamin D Status In Type 1 Diabetic Adults And Its Relationship With Glycemic Control
Objective: To assess the vitamin D levels between adults with type 1 diabetes mellitus and the healthy control group and evaluate the relationship between HbA1c levels and vitamin D status in the diabetic group. Methods: Our cross-sectional, descriptive study included 98 type 1 diabetic patients over 18 years old who applied to the Endocrinology Outpatient Clinic and 95 age- and sex-matched individuals without chronic disease. Patients with advanced renal or liver disorders, primary hyperparathyroidism, metabolic bone disorders, or using medications that might change vitamin D concentrations were excluded from the study. HbA1c and 25(OH) Vitamin-D3 levels were measured three times in 9 months, and the average of the measurements was used. Diabetic patients and control individuals were separated into three groups according to their vitamin D levels as follows: deficiency ( 20 ng/ml). Results: Serum 25 (OH) vitamin D levels of diabetic patients were significantly lower than in healthy individuals (p=0.024). However, when diabetic adults were separated into three groups according to 25(OH) vitamin D levels, there was no significant difference regarding HbA1c levels (p=0.905). Conclusion: Although preclinical data support the role of low serum vitamin D levels in the etiopathogenesis of type 1 diabetes mellitus, studies examining the connection between low serum vitamin D levels and the prevalence of type 1 diabetes or glycemic control are not sufficient to reach a clear conclusion, including our study.
- 21 October 2019
- Published by Polish Society for Magnesium Research in Journal of Elementology
- Vol. 25 (3/2020) , 1019-1028
Urine iodine excretion in patients with papillary thyroid cancer evaluation of the relationship with the presence of BRAF mutation
- 21 October 2019
- Published by Polish Society for Magnesium Research in Journal of Elementology
- Vol. 25 (3/2020) , 1019-1028
Urine iodine excretion in patients with papillary thyroid cancer evaluation of the relationship with the presence of BRAF mutation